Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

被引:342
作者
Kurose, K
Gilley, K
Matsumoto, S
Watson, PH
Zhou, XP
Eng, C [1 ]
机构
[1] Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA
[4] Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada
[5] Univ Cambridge, Human Canc Genet Res Grp, Canc Res UK, Cambridge CB2 2XZ, England
关键词
D O I
10.1038/ng1013
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have recently shown that loss of heterozygosity of specific markers, including those at 10q23, 17p13-p15 and 16q24, can occur in the stromal and epithelial compartments of primary invasive breast carcinomas. Here, we demonstrate high frequencies of somatic mutations in TP53 (encoding tumor protein p53) and PTEN (encoding phosphate and tensin homolog) in breast neoplastic epithelium and stroma. Mutations in TP53 and PTEN are mutually exclusive in either compartment. In contrast, mutations in WFDC1 (16q24, encoding WAP four-disulfide core domain 1) occur with low frequency in the stroma.
引用
收藏
页码:355 / 357
页数:3
相关论文
共 8 条
[1]  
ENG C, 2001, METABOLIC MOL BASES, V1, P979
[2]   Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions [J].
Kurose, K ;
Hoshaw-Woodard, S ;
Adeyinka, A ;
Lemeshow, S ;
Watson, PH ;
Eng, C .
HUMAN MOLECULAR GENETICS, 2001, 10 (18) :1907-1913
[3]   The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers [J].
Larsen, M ;
Ressler, SJ ;
Gerdes, MJ ;
Lu, B ;
Byron, M ;
Lawrence, JB ;
Rowley, DR .
MAMMALIAN GENOME, 2000, 11 (09) :767-773
[4]   Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers [J].
Mutter, GL ;
Lin, MC ;
Fitzgerald, JT ;
Kum, JB ;
Baak, JPA ;
Lees, JA ;
Weng, LP ;
Eng, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11) :924-931
[5]   Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast [J].
Perren, A ;
Weng, LP ;
Boag, AH ;
Ziebold, U ;
Thakore, K ;
Dahia, PLM ;
Komminoth, P ;
Lees, JA ;
Mulligan, LM ;
Mutter, GL ;
Eng, C .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1253-1260
[6]   Regulation of PTEN transcription by p53 [J].
Stambolic, V ;
MacPherson, D ;
Sas, D ;
Lin, Y ;
Snow, B ;
Jang, Y ;
Benchimol, S ;
Mak, TW .
MOLECULAR CELL, 2001, 8 (02) :317-325
[7]   Loss of heterozygosity analysis: Practically and conceptually flawed? [J].
Tomlinson, IPM ;
Lambros, MBK ;
Roylance, RR .
GENES CHROMOSOMES & CANCER, 2002, 34 (04) :349-353
[8]  
Wernert N, 2001, ANTICANCER RES, V21, P2259